speb/financial-data huggingface dataset:
FCNCN income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 219000000.00
FCNCN cash_flow (annual, 2024-12-31) — Repayment Of Debt: -450000000.00
FCNCN cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -1648000000.00
FCNCN income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 210000000.00
FCNCN balance_sheet (annual, 2024-12-31) — Retained Earnings: 19361000000.00
FCNCN income_statement (annual, 2024-12-31) — Salaries And Wages: 3078000000.00
FCNCN cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
FCNCN cash_flow (annual, 2024-12-31) — Sale Of Investment: 9515000000.00
FCNCN cash_flow (annual, 2024-12-31) — Sale Of PPE: 250000000.00
FCNCN income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 76000000.00
FCNCN income_statement (annual, 2024-12-31) — Selling General And Administration: 3511000000.00
FCNCN balance_sheet (annual, 2024-12-31) — Share Issued: 13717621.00
FCNCN cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
FCNCN cash_flow (quarterly, 2024-12-31) — Short Term Debt Issuance: 0.00
FCNCN cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
FCNCN cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
FCNCN income_statement (annual, 2024-12-31) — Special Income Charges: -182000000.00
FCNCN cash_flow (annual, 2024-12-31) — Stock Based Compensation: 0.00
FCNCN cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 0.00
FCNCN balance_sheet (annual, 2024-12-31) — Stockholders Equity: 22228000000.00
FCNCN balance_sheet (annual, 2024-12-31) — Tangible Book Value: 20725000000.00
FCNCN income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -41314000.00
FCNCN income_statement (annual, 2024-12-31) — Tax Provision: 815000000.00
FCNCN income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.23
FCNCN balance_sheet (annual, 2024-12-31) — Total Assets: 223720000000.00
FCNCN balance_sheet (annual, 2024-12-31) — Total Capitalization: 58897000000.00
FCNCN balance_sheet (annual, 2024-12-31) — Total Debt: 37041000000.00
FCNCN balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 22228000000.00
FCNCN balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 201492000000.00
FCNCN balance_sheet (annual, 2024-12-31) — Total Tax Payable: 3669000000.00
FCNCN balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 3669000000.00
FCNCN income_statement (annual, 2024-12-31) — Total Unusual Items: -182000000.00
FCNCN income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -182000000.00
FCNCN cash_flow (annual, 2024-12-31) — Unrealized Gain Loss On Investment Securities: -13000000.00
FCNCN income_statement (quarterly, 2025-03-31) — +Total Revenue: 2293000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 107000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 920000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1798000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Amortization: 15000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Amortization Of Intangibles Income Statement: 15000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 4000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 25029000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 814000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -273000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 376000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 894000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 25504000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 25849000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -42000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Cash Financial: 812000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 4777000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -4877000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 98000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 24000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -610000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -586000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Changes In Cash: -2000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Common Stock: 13000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 21414000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -618000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -40000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Deferred Tax: -40000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Defined Pension Benefit: 667000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 93000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 113000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 93000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 113000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 98000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 541000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 468000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 495000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — End Cash Position: 812000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 4777000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -175000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Gain Loss On Sale Of PPE: -6000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -5000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -199000000.00
FCNCN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 914000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Goodwill: 346000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 608000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 11715000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Held To Maturity Securities: 9874000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Income Tax Paid Supplemental Data: 40000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Insurance And Claims: 38000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Interest Expense: 1232000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Interest Income: 2895000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 1224000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 59334000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -4877000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 44455000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
FCNCN cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1242000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 376000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 37920000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 38296000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 1242000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -1000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 284000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -618000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Net Debt: 12416000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Net Income: 483000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 468000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 483000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 483000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 483000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 483000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 483000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Net Interest Income: 1663000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 157000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 1241000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 1241000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 18000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Net PPE: 11715000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -210000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Net Preferred Stock Issuance: 0.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 21687000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 3525000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 3525000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Normalized Income: 510454000.00
FCNCN income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 194000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 98000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -8000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Operating Revenue: 2293000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 13414938.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -199000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 262000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -7000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 173000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Other Properties: 11715000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Other Receivables: 5187000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 9552000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Other Special Charges: -5000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Payables: 107000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 107000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Preferred Shares Number: 8345000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 881000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Preferred Stock Dividends: 15000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Preferred Stock Equity: 881000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Preferred Stock Issuance: 0.00
FCNCN income_statement (quarterly, 2025-03-31) — Pretax Income: 651000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Professional Expense And Contract Services Expense: 25000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -2072000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -273000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Receivables: 6107000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 93000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Rent And Landing Fees: 58000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Rent Expense Supplemental: 58000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -1000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -618000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 42000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 19802000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Salaries And Wages: 818000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 2229000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 63000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 32000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 946000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Share Issued: 13414938.00
FCNCN income_statement (quarterly, 2025-03-31) — Special Income Charges: -37000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 22295000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 20806000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -9546000.00
FCNCN income_statement (quarterly, 2025-03-31) — Tax Provision: 168000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.26
FCNCN balance_sheet (quarterly, 2025-03-31) — Total Assets: 228822000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 60215000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Total Debt: 38296000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 22295000000.00
FCNCN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 206527000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Total Unusual Items: -37000000.00
FCNCN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -37000000.00
FCNCN cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 5000000.00
FCNCN income_statement (quarterly, 2025-06-30) — +Total Revenue: 2302000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 120000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 902000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1179000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Amortization: 13000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Amortization Of Intangibles Income Statement: 13000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 1000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 23454000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 812000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -341000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 419000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 894000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 27073000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 27373000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -40000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Cash Financial: 889000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -220000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -562000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 859000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -265000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 320000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 55000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Changes In Cash: 77000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Common Stock: 13000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 21415000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -613000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -34000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Deferred Tax: -34000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Defined Pension Benefit: 671000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 100000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 113000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 100000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 113000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 100000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Derivative Product Liabilities: 631000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 561000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 697000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — End Cash Position: 889000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -220000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 518000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: -7000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 2000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -114000000.00
FCNCN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 903000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Goodwill: 346000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 596000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Gross PPE: 11899000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Held To Maturity Securities: 9722000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 131000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Insurance And Claims: 38000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Interest Expense: 1250000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Interest Income: 2945000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 1198000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 58993000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -562000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 43486000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 0.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 419000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 37578000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 37997000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 0.00
FCNCN cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -351000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 288000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -613000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Net Debt: 10505000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Net Income: 575000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 561000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 575000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 575000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 575000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 575000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 575000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Net Interest Income: 1695000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 1165000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -351000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -351000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: -153000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Net PPE: 11899000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -280000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 21700000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3560000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 3560000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Normalized Income: 597770000.00
FCNCN income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 192000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 859000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -9000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Operating Revenue: 2302000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 13075979.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -114000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 250000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 58000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 129000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Other Properties: 11899000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Other Receivables: 5284000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 10310000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Other Special Charges: -8000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Payables: 120000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 120000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Preferred Shares Number: 8345000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 881000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Preferred Stock Dividends: 14000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Preferred Stock Equity: 881000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Pretax Income: 758000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Professional Expense And Contract Services Expense: 30000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -1056000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -341000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Receivables: 6186000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 100000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Rent And Landing Fees: 55000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Rent Expense Supplemental: 55000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -351000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -613000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 38000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 20337000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Salaries And Wages: 810000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 2221000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 61000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 32000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 935000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Share Issued: 13075979.00
FCNCN income_statement (quarterly, 2025-06-30) — Special Income Charges: -30000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 22296000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 20819000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -7230000.00
FCNCN income_statement (quarterly, 2025-06-30) — Tax Provision: 183000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
FCNCN balance_sheet (quarterly, 2025-06-30) — Total Assets: 229653000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 59874000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Total Debt: 37997000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 22296000000.00
FCNCN balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 207357000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Total Unusual Items: -30000000.00
FCNCN income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -30000000.00
FCNCN cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -2000000.00
FCNCN income_statement (quarterly, 2025-09-30) — +Total Revenue: 2430000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 105000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 945000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 270000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Amortization: 13000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Amortization Of Intangibles Income Statement: 13000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 0.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 22510000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 889000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -375000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 408000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Capital Stock: 894000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 25672000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Federal Funds Sold: 25755000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Cash Dividends Paid: -39000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Cash Financial: 874000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 2870000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -3801000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 916000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 155000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -55000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 100000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Changes In Cash: -15000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Common Stock: 13000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 21105000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -896000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -30000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Deferred Tax: -30000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Defined Pension Benefit: 670000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 91000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 111000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 91000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 111000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 98000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Derivative Product Liabilities: 520000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 554000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 825000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — End Cash Position: 874000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 2870000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 541000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -4000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 13000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -44000000.00
FCNCN income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 922000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Goodwill: 346000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 584000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Gross PPE: 12034000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Held To Maturity Securities: 9546000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 118000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Insurance And Claims: 38000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Interest Expense: 1264000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Interest Income: 2998000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 1241000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Invested Capital: 59290000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -3801000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 45284000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 597000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 408000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 38185000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 38593000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Long Term Debt Issuance: 597000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -3000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 265000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -896000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Net Debt: 12513000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Net Income: 568000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 554000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 568000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 568000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 568000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 568000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 568000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Net Interest Income: 1734000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -1591000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 594000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: 594000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
FCNCN cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 84000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Net PPE: 12034000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -304000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 21402000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 3580000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 3580000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Normalized Income: 586900000.00
FCNCN income_statement (quarterly, 2025-09-30) — Occupancy And Equipment: 195000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 916000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -12000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Operating Revenue: 2430000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 12618629.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -44000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 238000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 21000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Other Non Interest Expense: 176000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Other Properties: 12034000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Other Receivables: 5533000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 13228000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Other Special Charges: -3000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Payables: 105000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 105000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Preferred Shares Number: 8345000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 881000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 14000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Preferred Stock Equity: 881000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Pretax Income: 751000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Professional Expense And Contract Services Expense: 26000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -4737000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -375000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Receivables: 6478000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 91000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Rent And Landing Fees: 67000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Rent Expense Supplemental: 67000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -896000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 28000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 20866000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Salaries And Wages: 817000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 3146000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 71000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 33000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Selling General And Administration: 955000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Share Issued: 12618629.00
FCNCN income_statement (quarterly, 2025-09-30) — Special Income Charges: -25000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 21986000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 20521000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -6100000.00
FCNCN income_statement (quarterly, 2025-09-30) — Tax Provision: 183000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.24
FCNCN balance_sheet (quarterly, 2025-09-30) — Total Assets: 233488000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 60171000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Total Debt: 38593000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 21986000000.00
FCNCN balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 211502000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Total Unusual Items: -25000000.00
FCNCN income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -25000000.00
FCNCN cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -13000000.00
FCNCN income_statement (annual, 2025-12-31) — +Total Revenue: 9252000000.00
FCNCN income_statement (quarterly, 2025-12-31) — +Total Revenue: 2164000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Accounts Payable: 140000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 140000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Accounts Receivable: 912000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 912000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -1903000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -1903000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 0.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 0.00
FCNCN income_statement (annual, 2025-12-31) — Amortization: 54000000.00
FCNCN income_statement (quarterly, 2025-12-31) — Amortization: 13000000.00
FCNCN income_statement (annual, 2025-12-31) — Amortization Of Intangibles Income Statement: 54000000.00
FCNCN income_statement (quarterly, 2025-12-31) — Amortization Of Intangibles Income Statement: 13000000.00
FCNCN cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 6000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 1000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Available For Sale Securities: 3249000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 3249000000.00
FCNCN cash_flow (annual, 2025-12-31) — Beginning Cash Position: 814000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 874000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 1808000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 1808000000.00
FCNCN cash_flow (annual, 2025-12-31) — Capital Expenditure: -1562000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -573000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 401000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 401000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Capital Stock: 1387000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1387000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 20602000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 20602000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 20834000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Federal Funds Sold: 20834000000.00
FCNCN cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -161000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -40000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Cash Financial: 801000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Cash Financial: 801000000.00
FCNCN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2675000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -4752000000.00
FCNCN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -5611000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 3629000000.00
FCNCN cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 2923000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 1050000000.00
FCNCN cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -282000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -196000000.00
FCNCN cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 170000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 515000000.00
FCNCN cash_flow (annual, 2025-12-31) — Change In Working Capital: -112000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 319000000.00
FCNCN cash_flow (annual, 2025-12-31) — Changes In Cash: -13000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Changes In Cash: -73000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Common Stock: 12000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Common Stock: 12000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Common Stock Equity: 20863000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 20863000000.00
FCNCN cash_flow (annual, 2025-12-31) — Common Stock Payments: -3027000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -900000000.00
FCNCN cash_flow (annual, 2025-12-31) — Deferred Income Tax: -111000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -7000000.00
FCNCN cash_flow (annual, 2025-12-31) — Deferred Tax: -111000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Deferred Tax: -7000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Defined Pension Benefit: 784000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Defined Pension Benefit: 784000000.00
FCNCN cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 405000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 121000000.00
FCNCN income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 452000000.00
FCNCN income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 115000000.00
FCNCN cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 405000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 121000000.00
FCNCN income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 452000000.00
FCNCN income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 115000000.00
FCNCN income_statement (annual, 2025-12-31) — Depreciation Income Statement: 398000000.00
FCNCN income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 102000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 494000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 494000000.00
FCNCN income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 2149000000.00
FCNCN income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 566000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Employee Benefits: 1042000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1042000000.00
FCNCN cash_flow (annual, 2025-12-31) — End Cash Position: 801000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — End Cash Position: 801000000.00
FCNCN cash_flow (annual, 2025-12-31) — Financing Cash Flow: 2675000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -4752000000.00
FCNCN cash_flow (annual, 2025-12-31) — Free Cash Flow: 1361000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 477000000.00
FCNCN cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -3000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -3000000.00
FCNCN cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -32000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -15000000.00
FCNCN income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 25000000.00
FCNCN income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 15000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 83000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 83000000.00
FCNCN income_statement (annual, 2025-12-31) — General And Administrative Expense: 3679000000.00
FCNCN income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 940000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Goodwill: 346000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Goodwill: 346000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 573000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 573000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Gross PPE: 14265000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Gross PPE: 14265000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 9647000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 9647000000.00
FCNCN cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 315000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 26000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Income Tax Payable: 3819000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 3819000000.00
FCNCN income_statement (annual, 2025-12-31) — Insurance And Claims: 141000000.00
FCNCN income_statement (quarterly, 2025-12-31) — Insurance And Claims: 27000000.00
FCNCN income_statement (annual, 2025-12-31) — Interest Expense: 4964000000.00
FCNCN income_statement (quarterly, 2025-12-31) — Interest Expense: 1218000000.00
FCNCN income_statement (annual, 2025-12-31) — Interest Income: 11778000000.00
FCNCN income_statement (quarterly, 2025-12-31) — Interest Income: 2940000000.00
FCNCN cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 4810000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 1147000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Invested Capital: 56575000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Invested Capital: 56575000000.00
FCNCN cash_flow (annual, 2025-12-31) — Investing Cash Flow: -5611000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 3629000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Investments And Advances: 44686000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 44686000000.00
FCNCN cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 494000000.00
FCNCN cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1838000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: -1000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Land And Improvements: 496000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 496000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 401000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 401000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Long Term Debt: 35712000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 35712000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 36113000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 36113000000.00
FCNCN cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1838000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: -1000000.00
FCNCN cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -2850000000.00
FCNCN cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -2495000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Long Term Provisions: 260000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 260000000.00
FCNCN balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2046000000.00
FCNCN balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2046000000.00